It is important that CMOs engage authentically with internal and external audiences to advance their company goals. Read up on the insights Karla MacDonald, Chief Corporate Affairs Officer of Entrada Therapeutics, gives on this topic. Read the article here: https://lnkd.in/ebVSryQx #CMO #CMO360
Very insightful article, thanks Karla!
Vice President, Head Clinical Operations, Executive, Pharmaceutical, CRO, Consulting
This article by Abi Vainstein, MD, CMO is a quick read with valuable insights for #MDs in #academia considering a role as a #CMO in the #Biotech.
Being a CMO entails great responsibility and leadership duties. Abi Vainstein, MD, CMO of Sapience Therapeutics, Inc. discusses how CMOs can prepare for their roles and make the best first impressions. Read the article here: https://lnkd.in/gwS3Mdpv #CMO #chiefmedicalofficer #clinicalresearch
"You need to have something pretty special to attract people to your organization" TScan Therapeutics are investing heavily in their L&D programs and are definitely leading by example. The question is how long will it take the rest of the industry to catch up and will we see it have a direct impact on the retention rate among BioPharma firms? To read the full report, click on the link in the comments 👇
To read the full report, click on the link in the original post comments
Our latest BioPharma report found that companies have been heavily investing in operations over the past 12 months 📈 Ann Hargraves, Senior VP Human Resources at TScan Therapeutics, shares some additional insight around why operations is coming out on top as the fastest growing non-scientific skill. To read the full report, click on the link in the comments ⬇️
There is still time to join this week's virtual discussion analysing the #pharma industry's fastest growing and biggest selling drug brands. Register today! https://lnkd.in/dqbJu-9P Sponsored by Cencora Not sure you can join live? We've got you covered! Register and you will be able to view the event on-demand once it concludes. #biopharma #drugdevelopment #marketanalysis #pharmaceuticals
In this latest K-Cast series, “Advancing Healthcare With Prescription Drug Therapeutics,” Masha Salsabili, PharmD, PhD offers insights on the future of prescription digital therapeutics (PDTs) and how the landscape might evolve for PDTs over the next 5 years. Watch the series here: https://bit.ly/4dR4oLW #ManagedCare #HealthTech
Strategic planning starts in the lead up to launch, right? This is often true, but there are huge advantages to starting early, particularly for novel therapeutics. Download our whitepaper from FirstWord Pharma to explore the benefits and learn what you can do to get ahead: https://loom.ly/grhcxEw #drugdevelopment #strategicplanning #earlystrategy #pharma
It's never to soon to think strategically (but there are lots of reasons that often get in the way). In this article me and my fellow authors explore why early strategic thinking can give you a headstart in the drug development process and help you to avoid some of the potential roadblocks on your journey to patients. We also take a look at why this is even more important in emerging areas like cell and gene therapies where pathways are less established and the landscape is constantly changing
Strategic planning starts in the lead up to launch, right? This is often true, but there are huge advantages to starting early, particularly for novel therapeutics. Download our whitepaper from FirstWord Pharma to explore the benefits and learn what you can do to get ahead: https://loom.ly/grhcxEw #drugdevelopment #strategicplanning #earlystrategy #pharma
A fantastic article on the importance of early strategic planning for novel therapeutics authored by my wonderful colleagues in Evida and Seques with Manca Povsic from the AMICULUM Access team adding her insights from a market access perspective. Download the white paper to learn more and get in touch with myself or the team if you'd like to discuss your needs in this area. #marketaccess #earlystrategy #pharma #atmp
Strategic planning starts in the lead up to launch, right? This is often true, but there are huge advantages to starting early, particularly for novel therapeutics. Download our whitepaper from FirstWord Pharma to explore the benefits and learn what you can do to get ahead: https://loom.ly/grhcxEw #drugdevelopment #strategicplanning #earlystrategy #pharma
Co-Founder & Vice President, Discovery Research at Entrada Therapeutics
2moThanks for sharing your perspectives, Karla MacDonald great insights, learned a lot!